ArticleFrontiers in immunology2025

PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy.

Fei Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.